Talcum Powder Cancer Lawsuit

Will The Bankruptcy Strategy of Johnson & Johnson Outlast Legal Challenges Once Again

Johnson & Johnson is again attempting to manage lawsuits using bankruptcy

Sunday, March 2, 2025 - Among the most divisive legal disputes in business history, Johnson & Johnson finds a central role. Thousands of cases alleging major health issues resulting from its talc-based baby powder point to great potential culpability. Johnson & Johnson established a separate business to manage these claims, holding the legal obligations, then had that new company file for bankruptcy. This action was intended to reduce financial risk and provide a methodical approach to claim settlement. Courts have, however, asked frequently whether a financially robust firm like Johnson & Johnson ought to be let to apply for bankruptcy this way. The corporation is attempting once more after its first effort was turned down, contending that this is the most equitable approach to address the allegations. Arguing that the plan is only a means of postponing justice and controlling payouts, plaintiffs and their attorneys contend Anybody engaged in a baby powder litigation or looking for a talcum powder cancer attorney will be greatly affected by the ultimate ruling.

This legal fight centers on a tactic sometimes referred to as the "Texas two-step." Johnson & Johnson moved the legal responsibilities of its talc-related cases onto a newly formed company rather than declaring overall bankruptcy. After that, the subsidiary declared bankruptcy, putting all claims on wait as the business was processed through bankruptcy court. Johnson & Johnson contends that instead of dealing with erratic jury decisions, this strategy guarantees all applicants receive just pay. Courts had decided against this action, however, saying the corporation itself is not in financial crisis and therefore not be able to utilize bankruptcy to escape legal action. Many of the plaintiffs feel this is a delay strategy meant to keep their cases from being heard in court. Juries in conventional lawsuits can award significant damages, possibly far more than what bankruptcy settlements would offer. Johnson & Johnson increases control over settlements by filing cases into bankruptcy court, hence possibly lowering victim compensation. The plaintiffs contend that they should be free to bring their issues before a trial instead of being driven into a settlement under corporation control. Conversely, Johnson & Johnson maintains that its strategy is the best method to fairly and effectively manage the claims, therefore guaranteeing that all victims get something instead of running the danger of conflicting jury decisions.

Legal professionals disagree on whether Johnson & Johnson's updated bankruptcy plan will stand the courts. Some think the revisions in this most recent submission would be sufficient to address the court's worries. Others contend that judges would always view it as a misuse of the bankruptcy system. Should the courts reject the plan once more, Johnson & Johnson might be compelled to defend itself in conventional lawsuits, therefore subjecting itself to large financial penalties. Should the bankruptcy plan be granted, it may set a standard for other businesses dealing with extensive legal action.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.

More Recent Talcum Powder Ovarian Cancer Lawsuit News:

View all Talcum Powder Cancer Lawsuit News

No-Cost, No-Obligation Baby Powder Lawsuit Case Review for Persons or Families of Persons Who Developed Ovarian Cancer After a History of Perineal Baby Powder Use

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.